Product image of Monofer (Ferric Derisomaltose) supplied by GNH India

Monofer

Active Ingredient:
Ferric Derisomaltose
Origin:
EU

Monofer (Ferric Derisomaltose)

Ferric derisomaltose, the active ingredient in Monofer, is a Iron (III) carbohydrate complex presented as a solution for injection for intravenous use. It treats iron deficiency anemia in adults and pediatric patients where oral iron is ineffective or not tolerated.

GNH India supplies Monofer as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, providing reliable access to essential intravenous iron therapy for patients in need. The company ensures quality compliance and timely delivery across global markets.

Manufacturer / TM Owner

Pharmacosmos A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Monofer is used to treat iron deficiency anemia, a condition characterized by insufficient iron for normal red blood cell production.

  • Iron deficiency anemia: rapid replenishment of iron stores and increase in hemoglobin levels.
  • Chronic kidney disease‑associated anemia: provides intravenous iron to support erythropoiesis when oral iron is insufficient.
  • Pre‑operative anemia: corrects iron deficiency before surgery to reduce the need for blood transfusion.

How It Works

  • Ferric derisomaltose forms a stable iron‑carbohydrate complex that, after intravenous administration, is taken up by the reticuloendothelial system. The complex releases elemental iron in a controlled manner, allowing incorporation into hemoglobin and other iron‑dependent proteins, thereby restoring normal iron homeostasis and supporting erythropoiesis.

Side Effects

Common Side Effects

  • Nausea: mild to moderate discomfort in the stomach.
  • Headache: transient pain often resolving without intervention.
  • Injection site pain: localized discomfort at the infusion site.
  • Transient hypertension: brief increase in blood pressure during infusion.

Serious or Rare Side Effects

  • Anaphylactic reaction: severe allergic response requiring immediate medical attention.
  • Severe hypotension: marked drop in blood pressure that may cause dizziness or fainting.
  • Iron overload: excessive iron accumulation potentially leading to organ toxicity.

Precautions & Warnings

Before using Monofer, consider the following precautions:

  • Assess iron status: confirm diagnosis of iron deficiency anemia before administration.
  • Monitor for hypersensitivity: observe the patient during and after infusion for signs of allergic reaction.
  • Avoid rapid infusion rates: follow recommended administration guidelines to reduce adverse events.
  • Use with caution in active infection: iron may promote bacterial growth, so evaluate infection risk.
  • Contraindicated in known hypersensitivity to ferric derisomaltose or its excipients.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Monofer may interact with other medicines as follows:

Major Interactions (Avoid)

  • Other intravenous iron preparations: concurrent use increases risk of iron overload.
  • Erythropoiesis‑stimulating agents without iron monitoring: may exacerbate hypertension.
  • High‑dose vitamin C: can increase free iron levels and potentiate toxicity.

Moderate Interactions (Monitor Closely)

  • Oral iron supplements: may interfere with absorption; separate administration times.
  • Antacids containing aluminum or magnesium: may affect stability of the iron complex.
  • Chelating agents (e.g., deferoxamine): may bind released iron and reduce therapeutic efficacy.

Frequently Asked Questions

Monofer is an intravenous iron formulation indicated for the treatment of iron deficiency anemia, including cases associated with chronic kidney disease or where oral iron therapy is ineffective, poorly tolerated, or contraindicated.

Ferric derisomaltose is a stable iron‑carbohydrate complex that, after intravenous infusion, is taken up by macrophages in the reticuloendothelial system. The complex releases elemental iron in a controlled fashion, allowing incorporation into hemoglobin and other iron‑dependent proteins to restore normal erythropoiesis.

The prescribed dose of Monofer is individualized by the treating clinician based on the patient’s iron deficit, body weight, and clinical condition. The healthcare professional determines the total iron requirement and the appropriate infusion volume and rate.

Safety data for Ferric derisomaltose during pregnancy and lactation are limited. Use is generally reserved for situations where the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To order Monofer, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling if needed), and required import documentation.

Monofer delivers a large dose of elemental iron in a single infusion, reducing the number of administrations compared with iron sucrose or iron gluconate, which often require multiple sessions. Its carbohydrate complex provides a controlled release of iron, potentially lowering the incidence of acute reactions, though individual tolerability may vary.

Monofer should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Before use, inspect the solution for particulate matter or discoloration and allow it to reach room temperature if required by the administration protocol.

Monofer is administered intravenously as a single‑dose infusion. The solution is diluted according to the manufacturer’s instructions and infused over the recommended time period, typically ranging from 15 to 60 minutes, while the patient is monitored for any adverse reactions.

The most serious risks include severe hypersensitivity reactions such as anaphylaxis, marked hypotension, and iron overload, which can lead to organ damage. Prompt recognition and immediate medical intervention are essential if any of these events occur during or after infusion.

Monofer is contraindicated in patients with known hypersensitivity to ferric derisomaltose or any of its excipients. Caution is also advised for individuals with active infections, uncontrolled hypertension, or a history of severe allergic reactions to other intravenous iron products.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ferric Derisomaltose

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT